Teladoc Health, Inc. · NYSE:TDOC

Teladoc Health — Q3 2024 Earnings Presentation

14 slides from Teladoc Health's earnings presentation, Oct 30, 2024

  1. Slide 1: 3Q-24 Quarterly Results

    3Q-24 Quarterly Results Teladoc HEALTH

  2. Slide 2: Cautionary Note

    Cautionary Note • This presentation contains, and the officers of Teladoc Health, Inc. (the “Company” or “Teladoc Health”) may make, “forward-looking” statements that are based on management’s beliefs and assumptions and on information currently available to management. These forward-looking stateme

  3. Slide 3: Financial Highlights

    Financial Highlights 3Q-24 Net loss per share of $(0.19) 3Q-24 Revenue of includes amortization of 3Q-24 Adj. $641M, (3)% y/y acquired intangibles of $(0.30) EBITDA(1) of and stock-based compensation expense of $(0.20) per share $83.3M, (6)% y/y pre-tax Integrated Care Outlook Integrated Care Outloo

  4. Slide 4: 3Q-24 Consolidated Revenue & Adj. EBITDA

    3Q-24 Consolidated Revenue & Adj. EBITDA Revenue ($ millions) Adj. EBITDA ($ millions)(1) $100 $800 $88.8 $83.3 $660 $641 $80 $600 $60 $400 $40 $200 $20 $0 $0 3Q-23 3Q-24 3Q-23 3Q-24 (1) See reconciliation of GAAP to non-GAAP measures included in the Appendix of this presentation. 4

  5. Slide 5: 3Q-24: Segment Results

    (1) 3Q-24: Segment Results Integrated Care Segment Revenue ($ millions) BetterHelp Segment Revenue ($ millions) $600 $400 $300 $286 $276 $269 $374 $384 $377 $377 $384 $265 $257 $400 $200 $200 $100 $0 $0 3Q-23 4Q-23 1Q-24 2Q-24 3Q-24 3Q-23 4Q-23 1Q-24 2Q-24 3Q-24 Integrated Care Segment Adjusted EBIT

  6. Slide 6: 3Q-24 Revenue: U.S. & International

    3Q-24 Revenue: U.S. & International U.S. Revenue ($ millions) International Revenue ($ millions) $600 $569 $125 $536 $104 $500 $100 $91 $400 $75 $300 $50 $200 $25 $100 $0 $0 3Q-23 3Q-24 3Q-23 3Q-24 6

  7. Slide 7: 3Q-24: Quarterly Key Operating Metrics

    3Q-24: Quarterly Key Operating Metrics U.S. Integrated Care Members(1) (millions) BetterHelp Paying Users(2) (thousands) 100m 90.2 89.6 91.8 92.4 93.9 500k 459 425 415 407 398 50m 250k 0m 0k 3Q-23 4Q-23 1Q-24 2Q-24 3Q-24 3Q-23 4Q-23 1Q-24 2Q-24 3Q-24 Average Revenue per Month per U.S. Chronic Care P

  8. Slide 8: Quarterly Trend: Adj. Gross Margin, Adj. EBITDA, & Adj. EBITDA Margin

    Quarterly Trend: Adj. Gross Margin, Adj. EBITDA, & Adj. EBITDA Margin GAAP Gross Margin & Adj. Gross Margin(1) Adj. EBITDA(1) & Adj. EBITDA Margin ($ millions) $125m 75% 17.3% 18% 71.8% 71.9% 16% 70.7% 70.7% $100m 13.9% 69.9% 13.4% 13.0% 14% 70% 12% 68.6% 68.8% $75m 9.8% 67.2% 10% 66.7% 65% 65.8% $1

  9. Slide 9: Balance Sheet and Cash Flow Highlights

    Balance Sheet and Cash Flow Highlights • Cash and Cash Equivalents (as of September 3oth, 2024): $1.24B • Convertible Senior Notes (as of September 3oth, 2024): $1.54B • Operating Cash Flow (3Q-24): $110M • Free Cash Flow (1) (3Q-24): $79M (1) See reconciliation of GAAP to non-GAAP measures included

  10. Slide 10: Integrated Care Outlook: 4Q-24 and FY24

    Integrated Care Outlook: 4Q-24 and FY24 For the fourth quarter of 2024, we expect Revenue growth percentage (year-over-year) 0% - 2.5% Adjusted EBITDA margin 12.25% - 13.75% U.S. Integrated Care Members 93.5 - 94.5 million For the full year of 2024, we expect Revenue growth percentage (year-over-yea

  11. Slide 11: Appendix

    Teladc c. HEALTH © Appendix

  12. Slide 12: Reconciliation of Net Loss to Adjusted EBITDA

    Reconciliation of Net Loss to Adjusted EBITDA 3Q-23 4Q-23 1Q-24 2Q-24 3Q-24 Net loss $(57,073) $(28,890) $(81,889) $(837,671) $(33,276) Add: Provision for income taxes (2,484) 3,515 2,690 3,884 780 Other (income) expense, net 1,792 (1,537) 370 563 (2,239) Interest expense 5,646 5,538 5,649 5,648 5,6

  13. Slide 13: Reconciliation of GAAP Gross Profit to Adjusted Gross Profit

    Reconciliation of GAAP Gross Profit to Adjusted Gross Profit 3Q-23 4Q-23 1Q-24 2Q-24 3Q-24 Revenue $660,238 $660,527 $646,131 $642,444 $640,508 Cost of revenue (exclusive of depreciation and amortization, which are shown separately below) (185,960) (193,424) (194,538) (188,059) (179,745) Amortizatio

  14. Slide 14: Reconciliation of GAAP Net Cash Provided by Operating Activities to Free Cash Flow

    Reconciliation of GAAP Net Cash Provided by Operating Activities to Free Cash Flow 3Q-24 Net cash provided by operating activities $110,175 Capital expenditures (1,597) Capitalized software development costs (29,551) Capex (31,148) Free Cash Flow $79,027 (in 000s) 14

Teladoc Health — Q3 2024 Earnings Presentation on 6ix